Table 3 Patient characteristics at baseline telehealth encounter (N = 1208 encounters)
Variable | n | % |
|---|---|---|
Employed | ||
 Yes | 285 | 24 |
 No | 807 | 67 |
 Unknown | 116 | 9 |
Insurance status | ||
 Public Insurance | 1061 | 87.8 |
 Uninsured | 141 | 11.7 |
 Private Insurance | 3 | 0.2 |
 Unknown | 3 | 0.2 |
Area living ina | ||
 Metro | 864 | 72 |
 Small | 165 | 14 |
 Rural | 78 | 6.5 |
Opioid-related ED encounter | ||
 Yes | 203 | 16.9 |
 No | 1005 | 83.2 |
Naloxone administered | ||
 Yes | 200 | 16.6 |
 No | 998 | 82.6 |
Unknown | 10 | 0.8 |
Route of administration | ||
 Intravenous | 466 | 38.6 |
 Oral ingestion | 432 | 35.8 |
 Inhalation/Snorting | 188 | 15.6 |
 Smoking | 111 | 9.2 |
 Unknown | 11 | 0.9 |
Peer coach provided referral | ||
 Yes | 902 | 74.7 |
 No | 306 | 25.3 |
| Â | Mean | Standard Deviation |
Number ED encounters in previous 365 days | 10.8 | 17.9 |
Baseline telehealth interaction duration (in minutes) | 22.5 | 21.4 |